Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2633 followers
Created: 2025-07-21 20:02:16 UTC

AusperBio has obtained China CDE approval to progress AHB-137 to Phase III clinical trial for Chronic Hepatitis B treatment.

More Info: $XBI $IBB $XPH $PPH

![](https://pbs.twimg.com/media/GwaB2mUbEAEvq5m.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947386667628957812/c:line.svg)

**Related Topics**
[$pph](/topic/$pph)
[$xph](/topic/$xph)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)
[more info](/topic/more-info)
[china](/topic/china)

[Post Link](https://x.com/OzmosiHealth/status/1947386667628957812)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

OzmosiHealth Avatar Ozmosi @OzmosiHealth on x 2633 followers Created: 2025-07-21 20:02:16 UTC

AusperBio has obtained China CDE approval to progress AHB-137 to Phase III clinical trial for Chronic Hepatitis B treatment.

More Info: $XBI $IBB $XPH $PPH

XXX engagements

Engagements Line Chart

Related Topics $pph $xph $ibb $xbi more info china

Post Link

post/tweet::1947386667628957812
/post/tweet::1947386667628957812